Table 1.
Baseline (2010) characteristics of the diabetes and dyslipidemia cohorts
| Variables | Diabetes (N=51,879) |
Dyslipidemia (N=129,762) |
|---|---|---|
| Age (Mean, SD) | 72.5 (4.4) | 72.5 (4.4) |
| Female (%) | 55.8% | 58.2% |
| Caucasian race (%) | 73.9% | 83.7% |
| African-American race (%) | 15.8% | 9.4% |
| Other race (%) | 10.2% | 6.8% |
| Medicaid status (%) | 17.7% | 11.8% |
| Diabetes mellitus (%) | 100% | 42.2% |
| Hypertension (%) | 86.6% | 82.8% |
| Hyperlipidemia (%) | 80.2% | 100% |
| Heart failure (%) | 16.8% | 13.5% |
| Atrial fibrillation (%) | 8.1% | 8.3% |
| Dementia/Alzheimer’s/Related (%) | 5.9% | 4.9% |
| Anemia (%) | 29.3% | 25.1% |
| Asthma (%) | 5.0% | 4.8% |
| Cancer (%) | 8.9% | 9.4% |
| Chronic kidney disease (%) | 20.3% | 15.3% |
| COPD (%) | 10.8% | 10.9% |
| Depression (%) | 10.1% | 10.6% |
| Benign prostatic hyperplasia (%) | 7.3% | 7.9% |
| Acquired hypothyroidism (%) | 7.1% | 9.1% |
| Ischemic heart disease (%) | 42.6% | 43.7% |
| Osteoporosis (%) | 4.7% | 8.0% |
| Rheumatoid Arthritis/Osteoarthritis (%) | 31.5% | 32.7% |
| Stroke (%) | 4.2% | 4.2% |
| Number of all medications(Mean, SD) | 11.7 (5.8) | 10.1 (5.5) |
| # of prescribers of cardiometabolic medications with known specialty, 2010 (Mean, SD) |
1.8 (1.0) | 1.6 (0.9) |
Note: COPD = Chronic obstructive pulmonary disease, SD = standard deviation